Trial Search Results

Photoacoustic Imaging (PAI) of Suspicious Breast Cancers - A Clinical Feasibility Study

After locating the suspicious lesion/mass with standard of care mammography and/or ultrasound, a photoacoustic scan will be performed in the breast where the lesion is located. After the PA scan a biopsy will be performed, if clinically indicated (based on the mammogram and ultrasound only).

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):


  • Procedure: Photoacoustic Imaging (PAI)




Inclusion Criteria:

   - Patients must have a breast lesion/mass found at physical examination, mammography or
   ultrasound (US), that has not been surgically resected

   - Patients may have any of the following characteristics:

      - Taking hormones (e.g., contraceptives, hormone replacement therapy, post-cancer

      - Breast implants

      - Previous breast biopsy

      - Previous breast surgery

      - Previous breast cancer

      - High risk of breast cancer (e.g., breast cancer susceptibility gene (BRCA)
      mutations, other gynecologic cancer)

   - Ability to understand and the willingness to sign a written informed consent document

Exclusion Criteria:

   - Patients who have had primary surgical excision of the suspicious finding

   - Pregnant or lactating women

Ages Eligible for Study

18 Years - 80 Years

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Not Recruiting